YQA-14

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameYQA-14
Drug Alias NameYQA-14
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor antagonists
TargetsDopamine D3 receptor
Therapy Area/IndicationsSubstance-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSubstance-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A